VRTX•benzinga•
Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?
Summary
Vertex posted Q1 EPS and sales below estimates but raised its 2025 revenue outlook, driven by CF drug demand and new product launches in the U.S.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 6, 2025 by benzinga